NCT00533832View on ClinicalTrials.gov

Pivotal Trial (D02) of Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depression (TRD)

NACompletedINTERVENTIONAL

Enrollment

266

Participants

Timeline

Start Date

July 31, 2000

Study Completion Date

July 31, 2005

Conditions

Major Depressive Disorder

Interventions

DEVICE

vagus nerve stimulation (VNS)

"intermittent vagus nerve stimulation~Placebo group were implanted, but did not receive vagus nerve stimulation during the acute phase."

Trial Locations (1)

Unknown

Houston

Sponsors

Lead Sponsor

Cyberonics, Inc.

All Listed Sponsors

lead

Cyberonics, Inc.

INDUSTRY

NCT00533832 - Pivotal Trial (D02) of Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depression (TRD) | Biotech Hunter | Biotech Hunter